Biomet has appointed Jeffrey Binder as president and CEO. He replaces the company's former general counsel Daniel Hann, who took on the role on an interim basis in March 2006, when co-founder Dane Miller stepped down from the posts.
Mr Binder has been senior vice-president of Abbott Laboratories' diagnostics activities since January 2006. He joined Abbott in 2003, when...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?